Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$5.96 - $8.53 $534,057 - $764,347
-89,607 Reduced 82.86%
18,537 $158,000
Q3 2022

Oct 31, 2022

SELL
$5.95 - $14.3 $5.35 Million - $12.9 Million
-899,269 Reduced 89.27%
108,144 $666,000
Q2 2022

Jul 29, 2022

BUY
$10.6 - $13.28 $8.04 Million - $10.1 Million
758,555 Added 304.81%
1,007,413 $12 Million
Q1 2022

Apr 29, 2022

BUY
$10.37 - $12.73 $2.58 Million - $3.17 Million
248,858 New
248,858 $2.91 Million
Q4 2021

Feb 07, 2022

SELL
$10.21 - $15.27 $90,603 - $135,505
-8,874 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$14.07 - $17.3 $124,857 - $153,520
8,874 New
8,874 $130,000
Q1 2021

May 13, 2021

SELL
$15.15 - $19.78 $102,201 - $133,435
-6,746 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$16.86 - $19.67 $113,737 - $132,693
6,746 New
6,746 $124,000
Q1 2020

Apr 30, 2020

SELL
$16.28 - $25.63 $6.44 Million - $10.1 Million
-395,298 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$19.57 - $23.52 $7.74 Million - $9.3 Million
395,298 New
395,298 $9.21 Million
Q2 2019

Jul 29, 2019

SELL
$17.59 - $21.1 $146,929 - $176,248
-8,353 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$18.01 - $20.11 $9,203 - $10,276
511 Added 6.52%
8,353 $168,000
Q4 2018

Feb 01, 2019

BUY
$17.44 - $21.53 $136,764 - $168,838
7,842 New
7,842 $144,000
Q3 2018

Nov 06, 2018

SELL
$19.97 - $21.96 $59.9 Million - $65.9 Million
-3,001,189 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$20.16 - $24.68 $60.3 Million - $73.9 Million
2,993,491 Added 38886.61%
3,001,189 $64.5 Million
Q1 2018

May 03, 2018

SELL
$20.31 - $24.95 $187,136 - $229,889
-9,214 Reduced 54.48%
7,698 $163,000
Q4 2017

Jan 24, 2018

SELL
$20.99 - $23.89 $102,410 - $116,559
-4,879 Reduced 22.39%
16,912 $388,000
Q3 2017

Nov 07, 2017

BUY
$20.07 - $21.89 $437,345 - $477,004
21,791
21,791 $477,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.